BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• MedMira Provides a Pre-Annual General Meeting Update

  Today, MedMira Inc. (MedMira) (TSXV: MIR) provides a pre-Annual General Meeting (AGM) update on its regulatory and product development progress.

  February 4, 2022

   · 

  5 min read
• Biotech Bay

  Shockwave Medical to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

  Shockwave Medical, Inc. announced today that the company will be participating in the SVB Leerink 11th Annual Global Healthcare Conference, scheduled to be held virtually from February 14-18, 2022.

  February 4, 2022

   · 

  1 min read
• /R E P E A T - NOTICE TO THE MEDIA - The Minister of Health and Government of Canada officials to hold a news conference on coronavirus disease (February 4, 2022)/

  The Honourable Jean-Yves Duclos, Minister of Health, and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19).

  February 4, 2022

   · 

  1 min read
• Genetown

  Hemab Therapeutics Announces First Drug Candidate: HMB-001, a Novel Bispecific Antibody with Potential for Treatment of Rare Bleeding Disorders

  Preclinical data demonstrate HMB-001’s promise as a preventative treatment for patients with underserved bleeding disorders, including Glanzmann Thrombasthenia.

  February 4, 2022

   · 

  3 min read
• Biotech Bay

  Outset Medical to Present at SVB Leerink Global Healthcare Conference

  Outset Medical, Inc. today announced that members of management will participate in a fireside chat at the SVB Leerink 11th Annual Global Healthcare Conference on Friday, February 18, 2022 at 12:40pm PT / 3:40pm ET.

  February 4, 2022

   · 

  1 min read
• Deals

  Nuvectis Pharma, Inc. Announces Pricing of $16,000,000 Upsized Initial Public Offering of Common Stock

  Nuvectis Pharma, Inc. today announced the pricing of its initial public offering of 3,200,000 shares of common stock at a public offering price of $5.00 per share, for gross proceeds of $16,000,000, before deducting underwriting discounts and commissions.

  February 4, 2022

   · 

  3 min read
• Business

  Amolyt Pharma Selected for the French Tech 120 Program

  Amolyt Pharma today announced that the company has been selected for the French Tech FT120.

  February 4, 2022

   · 

  2 min read
• Biotech Bay

  Late-breaking Data Presented at SMFM 2022 Annual Meeting Shows The Mirvie RNA Platform is First to Reveal The Underlying Biology of Preterm Birth

  Mirvie, a pioneer in predicting unexpected pregnancy complications, announced data presented at the Society for Maternal-Fetal Medicine 42nd Annual Pregnancy Meeting demonstrates the Mirvie RNA platform is first to predict preterm birth by revealing the underlying biology of each pregnancy.

  February 4, 2022

   · 

  5 min read
• BioCapital

  Gain Therapeutics Outlines Key Objectives for 2022 Following its Inaugural R&D Day

  Gain Therapeutics, Inc. today held its inaugural research and development day webinar.

  February 4, 2022

   · 

  4 min read
• Genetown

  Azenta Life Sciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

  Azenta, Inc. announced that Company management will participate in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15, 2022, which includes a presentation beginning at 10:30 a.m. EST.

  February 4, 2022

   · 

  1 min read